35
Participants
Start Date
August 28, 2019
Primary Completion Date
October 1, 2024
Study Completion Date
October 1, 2024
Nivolumab
60 Minute IV Infusion
Belfast City Hospital, Belfast
Queen Elizabeth Hospital, Birmingham
Velindre Cancer Centre, Cardiff
Western General Hospital, Edinburgh
Clatterbridge Cancer Centre, Liverpool
Guys Hospital, London
The Royal Marsden NHS Foundation Trust, London
University College Hospital, London
The Christie Hospital, The Christie NHS Foundation Trust, Manchester
Freemans Hospital, Newcastle upon Tyne
St James Leeds, Leeds
Leicester Royal Infirmary, Leicester
The Royal Free Hospital, London
Weston Park, Sheffield
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
University of Birmingham
OTHER